Ivermectin is an antiparasitic medication used to treat multiple helminthic (worm) and ectoparasitic conditions in humans. The concept in the provided post that parasites exist “in every part of our bodies” and are physically “broken off” by ivermectin reflects a common misconception. In clinical medicine, parasites are specific organisms (for example, Onchocerca volvulus, Strongyloides stercoralis, or scabies mites), and their location depends on the species’ biology and the host’s immune response. Ivermectin does not broadly “detox” or cause parasites to detach from all tissues indiscriminately; rather, it targets defined neuromuscular pathways in susceptible parasites.
Mechanism of action: Ivermectin binds selectively to glutamate-gated chloride channels and, in some species, to GABA-A–mediated chloride channels in parasite nerve and muscle cells. This binding increases chloride conductance, leading to hyperpolarization, paralysis, and death of the parasite. Because human cells do not express these parasite-specific ligand-gated chloride channels in the same functional way, ivermectin has a favorable therapeutic index. The drug’s efficacy varies by parasite species, developmental stage, and tissue penetration.
Approved or established uses include onchocerciasis (river blindness), strongyloidiasis (especially in uncomplicated intestinal disease), lymphatic filariasis, and scabies in many health systems. It is also used for other parasitic indications depending on local guidelines and regulatory approvals. For scabies, ivermectin is typically administered orally (often with repeat dosing) and may be used in combination with topical therapies in severe or outbreak settings. For strongyloidiasis, clinicians choose dosing regimens based on disease severity, immune status, and risk of disseminated infection.
Important limitation: Disseminated strongyloidiasis is a medical emergency. Immunosuppression (including corticosteroids, hematologic malignancy, transplant medications) increases risk of autoinfection and systemic spread. If symptoms such as fever, hypotension, respiratory compromise, or severe gastrointestinal involvement occur, urgent evaluation is needed. A key reason misinformation spreads is that ivermectin can be effective when the correct diagnosis is made, but it is not a universal cure for non-specific symptoms.
Diagnosis and monitoring: Parasitic infections are usually confirmed by history, exposure risk, and laboratory testing (stool ova and parasite examinations, serology, antigen tests, skin microscopy for scabies, or specialized tests for onchocerciasis where available). Monitoring depends on the infection: for onchocerciasis, clinical and sometimes ocular outcomes are tracked; for scabies, symptom improvement is expected but post-scabetic pruritus may persist for weeks despite parasite clearance.
Safety and adverse effects: Ivermectin is generally well tolerated. Common adverse effects include dizziness, fatigue, nausea, diarrhea, and pruritus. Serious reactions are uncommon but can occur, particularly in heavy onchocerciasis loads where rapid parasite killing can trigger inflammatory responses. Neurologic toxicity has been reported rarely, especially in patients with conditions that impair drug transport across the blood-brain barrier. A known risk factor is the presence of specific genetic variants affecting P-glycoprotein transport (for example, rare variants in the ABCB1 gene) and, in some contexts, high-dose exposures. In endemic regions, clinicians consider these risks when treating mass populations.
Drug interactions: Ivermectin is metabolized primarily by CYP3A4 and is a substrate for P-glycoprotein; therefore, inhibitors or inducers of these pathways can alter drug levels. Clinicians review current medications, including antifungals, macrolide antibiotics, antiepileptics, and immunosuppressants, to avoid reduced efficacy or toxicity.
Public health context: Prevention is grounded in sanitation, safe water, food safety, and targeted deworming strategies for specific endemic diseases. “Anti-parasitic foods and roughage” are not substitutes for diagnosis and evidence-based therapy. While dietary fiber may support bowel health, it does not reliably eradicate helminths. The most important “next step” after possible exposure is medical evaluation rather than attributing all bodily symptoms to undiagnosed parasites.
Conclusion: Ivermectin is a mechanism-based antiparasitic that treats specific infections by paralyzing susceptible parasites through chloride channel modulation. Its effectiveness depends on correct organism identification, dosing regimen, and patient immune status. Misinterpretations that parasites are universally present everywhere and are mechanically “broken off” by ivermectin risk delaying appropriate care, especially for severe or disseminated disease. Source: @mcgillmedicines
mcgill_medicines: The OUTER PARASITES are broken off each time we use IVERMECTIN or eat anti-parasitic foods & roughage. The parasites are in EVERY part of our bodies – feet, legs, brain, eyes, glands, organs, cells, skin, breasts, testicles…. As we eat infected, GMO, manufactured. #breaking
— @mcgillmedicines May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
